Shopping Cart 0
Cart Subtotal
AED 0

Otsuka Holdings Co Ltd (4578) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies. The company's product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co Ltd (4578)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Otsuka Holdings Co Ltd, Medical Equipment, Deal Details 14

Venture Financing 14

Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14

Megakaryon Raises USD9.7 Million in Series C Financing 15

Science 37 Raises USD35 Million in Series C Financing 17

Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19

Zenomics Raises USD5.8 Million in Financing 20

ReCor Medical Raises USD10 Million in Venture Financing 21

ReCor Medical Raises USD15 Million in Series D Financing 22

Proteus Digital Health Raises USD 63 Million In Series F Financing Round 23

Private Equity 24

MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24

Partnerships 26

Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26

Safe Orthopedics Signs Partnership Agreement with KiSCO 27

Science 37 Enters into Agreement with Otsuka Pharma 28

MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29

Shanghai MicroPort Enters into Agreement with Wiltrom 30

Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31

MicroPort Scientific Enters into Agreement with MinInvasive 32

Otsuka Enters into Agreement with ReCor Medical 33

Otsuka Medical and UriCare Form Joint Venture 34

Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35

Shanghai MicroPort Partners with Second Military Medical University 36

MicroPort Scientific Forms Joint Venture with Sorin 37

ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38

Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39

Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41

C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42

Gavis Pharma Partners with Nichiban 43

Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44

MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45

NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46

Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47

Equity Offering 48

MinInvasive Raises Funds through Private Placement of Shares 48

Otsuka Invests in ReCor Medical 49

Debt Offering 50

MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50

Acquisition 51

Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51

Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52

Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54

Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55

MicroPort Scientific Plans To Acquire Medical Device Company 56

MicroPort Acquires D-Pulse Medical 57

MicroPort Scientific Acquires Winning Forward For USD 5.3 Million 58

MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To USD 17 Million 59

Otsuka Holdings Co Ltd-Key Competitors 60

Otsuka Holdings Co Ltd-Key Employees 61

Otsuka Holdings Co Ltd-Locations And Subsidiaries 62

Head Office 62

Other Locations & Subsidiaries 62

Recent Developments 65

Strategy And Business Planning 65

Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 65

Financial Announcements 66

Aug 08, 2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018 66

Feb 14, 2018: Otsuka Holdings announces Consolidated Financial Results for the Fiscal Year Ended December 31, 2017 73

Nov 14, 2017: Otsuka Holdings: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2017 76

May 12, 2017: Otsuka Holdings Company Reports Net Sales Of JPY280.2 Billion In Q1 2017 78

Feb 14, 2017: Otsuka Holdings Company Reports Net Sales Of JPY1.2 Trillion In 2016 79

Corporate Communications 80

Mar 29, 2018: Otsuka Holdings appoints board members and audit & supervisory board members 80

Feb 14, 2018: Otsuka Holdings Announces Personnel Changes 81

Mar 30, 2017: Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members 83

Feb 14, 2017: Otsuka Holdings Announces Personnel Changes 84

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85


List Of Figure

List of Figures

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Otsuka Holdings Co Ltd, Medical Equipment, Key Facts, 2017 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Deals By Market, 2012 to YTD 2018 10

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14

Megakaryon Raises USD9.7 Million in Series C Financing 15

Science 37 Raises USD35 Million in Series C Financing 17

Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19

Zenomics Raises USD5.8 Million in Financing 20

ReCor Medical Raises USD10 Million in Venture Financing 21

ReCor Medical Raises USD15 Million in Series D Financing 22

Proteus Digital Health Raises USD 63 Million In Series F Financing Round 23

MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24

Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26

Safe Orthopedics Signs Partnership Agreement with KiSCO 27

Science 37 Enters into Agreement with Otsuka Pharma 28

MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29

Shanghai MicroPort Enters into Agreement with Wiltrom 30

Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31

MicroPort Scientific Enters into Agreement with MinInvasive 32

Otsuka Enters into Agreement with ReCor Medical 33

Otsuka Medical and UriCare Form Joint Venture 34

Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35

Shanghai MicroPort Partners with Second Military Medical University 36

MicroPort Scientific Forms Joint Venture with Sorin 37

ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38

Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39

Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41

C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42

Gavis Pharma Partners with Nichiban 43

Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44

MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45

NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46

Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47

MinInvasive Raises Funds through Private Placement of Shares 48

Otsuka Invests in ReCor Medical 49

MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50

Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51

Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52

Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54

Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55

MicroPort Scientific Plans To Acquire Medical Device Company 56

MicroPort Acquires D-Pulse Medical 57

MicroPort Scientific Acquires Winning Forward For USD 5.3 Million 58

MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To USD 17 Million 59

Otsuka Holdings Co Ltd, Key Competitors 60

Otsuka Holdings Co Ltd, Key Employees 61

Otsuka Holdings Co Ltd, Subsidiaries 62

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Otsuka Holdings Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies. The company's product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co Ltd (4578)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Otsuka Holdings Co Ltd, Medical Equipment, Deal Details 14

Venture Financing 14

Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14

Megakaryon Raises USD9.7 Million in Series C Financing 15

Science 37 Raises USD35 Million in Series C Financing 17

Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19

Zenomics Raises USD5.8 Million in Financing 20

ReCor Medical Raises USD10 Million in Venture Financing 21

ReCor Medical Raises USD15 Million in Series D Financing 22

Proteus Digital Health Raises USD 63 Million In Series F Financing Round 23

Private Equity 24

MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24

Partnerships 26

Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26

Safe Orthopedics Signs Partnership Agreement with KiSCO 27

Science 37 Enters into Agreement with Otsuka Pharma 28

MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29

Shanghai MicroPort Enters into Agreement with Wiltrom 30

Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31

MicroPort Scientific Enters into Agreement with MinInvasive 32

Otsuka Enters into Agreement with ReCor Medical 33

Otsuka Medical and UriCare Form Joint Venture 34

Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35

Shanghai MicroPort Partners with Second Military Medical University 36

MicroPort Scientific Forms Joint Venture with Sorin 37

ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38

Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39

Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41

C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42

Gavis Pharma Partners with Nichiban 43

Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44

MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45

NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46

Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47

Equity Offering 48

MinInvasive Raises Funds through Private Placement of Shares 48

Otsuka Invests in ReCor Medical 49

Debt Offering 50

MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50

Acquisition 51

Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51

Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52

Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54

Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55

MicroPort Scientific Plans To Acquire Medical Device Company 56

MicroPort Acquires D-Pulse Medical 57

MicroPort Scientific Acquires Winning Forward For USD 5.3 Million 58

MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To USD 17 Million 59

Otsuka Holdings Co Ltd-Key Competitors 60

Otsuka Holdings Co Ltd-Key Employees 61

Otsuka Holdings Co Ltd-Locations And Subsidiaries 62

Head Office 62

Other Locations & Subsidiaries 62

Recent Developments 65

Strategy And Business Planning 65

Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 65

Financial Announcements 66

Aug 08, 2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018 66

Feb 14, 2018: Otsuka Holdings announces Consolidated Financial Results for the Fiscal Year Ended December 31, 2017 73

Nov 14, 2017: Otsuka Holdings: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2017 76

May 12, 2017: Otsuka Holdings Company Reports Net Sales Of JPY280.2 Billion In Q1 2017 78

Feb 14, 2017: Otsuka Holdings Company Reports Net Sales Of JPY1.2 Trillion In 2016 79

Corporate Communications 80

Mar 29, 2018: Otsuka Holdings appoints board members and audit & supervisory board members 80

Feb 14, 2018: Otsuka Holdings Announces Personnel Changes 81

Mar 30, 2017: Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members 83

Feb 14, 2017: Otsuka Holdings Announces Personnel Changes 84

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85


List Of Figure

List of Figures

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Otsuka Holdings Co Ltd, Medical Equipment, Key Facts, 2017 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Otsuka Holdings Co Ltd, Deals By Market, 2012 to YTD 2018 10

Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14

Megakaryon Raises USD9.7 Million in Series C Financing 15

Science 37 Raises USD35 Million in Series C Financing 17

Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19

Zenomics Raises USD5.8 Million in Financing 20

ReCor Medical Raises USD10 Million in Venture Financing 21

ReCor Medical Raises USD15 Million in Series D Financing 22

Proteus Digital Health Raises USD 63 Million In Series F Financing Round 23

MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24

Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26

Safe Orthopedics Signs Partnership Agreement with KiSCO 27

Science 37 Enters into Agreement with Otsuka Pharma 28

MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29

Shanghai MicroPort Enters into Agreement with Wiltrom 30

Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31

MicroPort Scientific Enters into Agreement with MinInvasive 32

Otsuka Enters into Agreement with ReCor Medical 33

Otsuka Medical and UriCare Form Joint Venture 34

Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35

Shanghai MicroPort Partners with Second Military Medical University 36

MicroPort Scientific Forms Joint Venture with Sorin 37

ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38

Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39

Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41

C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42

Gavis Pharma Partners with Nichiban 43

Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44

MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45

NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46

Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47

MinInvasive Raises Funds through Private Placement of Shares 48

Otsuka Invests in ReCor Medical 49

MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50

Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51

Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52

Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54

Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55

MicroPort Scientific Plans To Acquire Medical Device Company 56

MicroPort Acquires D-Pulse Medical 57

MicroPort Scientific Acquires Winning Forward For USD 5.3 Million 58

MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To USD 17 Million 59

Otsuka Holdings Co Ltd, Key Competitors 60

Otsuka Holdings Co Ltd, Key Employees 61

Otsuka Holdings Co Ltd, Subsidiaries 62

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Otsuka Holdings Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.